Home Family Medicine Pain in the Arm and Hand

Pain in the Arm and Hand

📋 Key Information Summary

📋
  • Arm and hand pain is a common presenting complaint in Australian general practice, accounting for a significant proportion of musculoskeletal consultations.
  • Use a systematic diagnostic model — localise pain by compartment (lateral, medial, anterior, posterior), assess for neurological compromise, and identify red-flag features (night pain, progressive weakness, systemic symptoms).
  • Tennis elbow (lateral epicondylar tendinopathy) is the most common cause of lateral elbow pain; diagnosis is clinical with pain on resisted wrist extension and tenderness over the lateral epicondyle.
  • Medial epicondylar tendinopathy ("golfer's elbow") presents with medial elbow pain worsened by resisted wrist flexion and pronation; less common than lateral epicondylitis but follows the same evidence-based management principles.
  • First-line management for epicondylar tendinopathy is progressive eccentric loading exercises, activity modification, and short-term analgesia; corticosteroid injections may provide short-term relief but are associated with higher recurrence rates.
  • Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy; diagnosis is clinical with nocturnal paraesthesia, thenar weakness, and positive Phalen's/Tinel's tests.
  • Nerve conduction studies (NCS) are recommended for CTS when diagnosis is uncertain or surgery is being considered; available in major Australian centres (MBS item 11014).
  • Conservative CTS management includes wrist splints (especially nocturnal), ergonomic modification, and corticosteroid injection; surgical decompression (carpal tunnel release) is indicated for refractory or severe cases with thenar atrophy.
  • Pulled elbow (radial head subluxation) is a common paediatric injury typically in children aged 1–4 years, caused by longitudinal traction on the forearm with the arm extended.
  • Pulled elbow reduction is achieved by supination–flexion or hyperpronation technique in the clinic or ED; success rates exceed 80% with the first attempt and the child should use the arm within 10–15 minutes.
  • Always exclude non-accidental injury (NAI) in young children presenting with arm pain, particularly if the mechanism of injury is inconsistent or there are other injuries.
  • Red flags requiring urgent imaging or referral include open fractures, neurovascular compromise, suspected septic arthritis, compartment syndrome, and progressive intrinsic hand muscle wasting.

Introduction & Australian Epidemiology

Pain in the arm and hand is one of the most common musculoskeletal presentations in Australian primary care. The upper limb is a complex structure comprising the shoulder girdle, arm (brachium), elbow, forearm, wrist, and hand — each anatomical region susceptible to distinct patterns of injury, overuse, entrapment neuropathy, and inflammatory disease. Effective diagnosis requires a structured regional approach that combines history, targeted examination, and selective investigation.

In Australia, musculoskeletal conditions affect approximately 7.3 million people and are the leading cause of disability (AIHW, 2024). Upper limb disorders account for roughly one-quarter of all musculoskeletal consultations in general practice (Britt et al., 2023). Lateral epicondylar tendinopathy has an annual incidence of 1–3% in the general population, with peak prevalence in adults aged 35–54 years. Carpal tunnel syndrome affects an estimated 3–6% of Australian adults and is the most common entrapment neuropathy worldwide. Pulled elbow (radial head subluxation) is one of the most frequent upper limb injuries in young children presenting to paediatric emergency departments.

This article provides an evidence-based diagnostic and management framework for the most clinically important causes of arm and hand pain encountered in Australian general practice, emergency medicine, and paediatrics.

⚠️
Red flags — refer urgently: Open fractures, neurovascular compromise (absent pulses, paraesthesia distal to injury), suspected compartment syndrome (pain out of proportion, tense compartment, pain with passive stretch), septic arthritis of the elbow or wrist, suspected malignancy (night pain, weight loss, mass), or signs of cervical radiculopathy with progressive motor deficit.

Arm & Hand Diagnostic Model

A systematic approach to arm and hand pain involves localising the site of pathology, determining the mechanism (acute traumatic, overuse/ repetitive strain, insidious onset), identifying red flags, and correlating findings with the relevant anatomical structures. The following compartmental model helps clinicians narrow the differential diagnosis efficiently.

Compartment / Region Common Diagnoses Key Clinical Features
Lateral elbow Lateral epicondylar tendinopathy (tennis elbow), radial tunnel syndrome, osteochondritis dissecans Pain over lateral epicondyle, aggravated by gripping and wrist extension; point tenderness over ECRB origin
Medial elbow Medial epicondylar tendinopathy (golfer's elbow), cubital tunnel syndrome, UCL sprain (throwing athletes) Medial elbow pain, worse with wrist flexion/pronation; ulnar nerve paraesthesia in ring and little fingers suggests cubital tunnel
Posterior elbow Olecranon bursitis, triceps tendinopathy, olecranon stress fracture, posterior impingement Swelling over olecranon (bursitis), pain with resisted extension (triceps tendinopathy)
Anterior forearm Flexor-pronator tendinopathy, acute compartment syndrome, median nerve entrapment (proximal) Forearm pain with gripping; tense forearm compartment in compartment syndrome
Wrist — volar Carpal tunnel syndrome, Guyon's canal syndrome, flexor tenosynovitis (trigger finger) Nocturnal paraesthesia in median nerve distribution (CTS); ulnar nerve symptoms (Guyon's)
Wrist — dorsal De Quervain's tenosynovitis, dorsal wrist ganglion, scaphoid fracture, intersection syndrome Finkelstein's test positive (De Quervain's); anatomical snuffbox tenderness (scaphoid)
Hand — fingers Mallet finger, Boutonnière deformity, Dupuytren's contracture, PIP/DIP osteoarthritis, flexor tendon injury Loss of active extension at DIP (mallet), inability to extend at PIP with hyperextension at DIP (Boutonnière)
Paediatric arm Pulled elbow (radial head subluxation), supracondylar fracture, distal radius fracture (buckle/ greenstick) Refusal to use arm after traction injury (pulled elbow); swelling and deformity after fall (fracture)

Stepwise Diagnostic Approach

1
History
Onset (acute vs insidious), mechanism (trauma, repetitive activity, traction in children), site of pain, aggravating/relieving factors, night symptoms, functional impact (gripping, lifting), occupation and sport.
2
Inspection & Palpation
Look for swelling, deformity, muscle wasting (thenar/hypothenar), erythema. Palpate bony landmarks (epicondyles, radial head, anatomical snuffbox) and soft-tissue structures (flexor/extensor tendons, nerves).
3
Provocation Tests
Resisted wrist extension (tennis elbow), resisted wrist flexion (golfer's elbow), Phalen's and Tinel's tests (CTS), Finkelstein's test (De Quervain's), Cozen's test, grip strength assessment.
4
Neurovascular Assessment
Sensation in median, ulnar, and radial nerve distributions; intrinsic hand muscle strength (abductor pollicis brevis, first dorsal interosseous); pulses; capillary refill.
5
Selective Investigation
X-ray for suspected fracture or dislocation; ultrasound for tendinopathy/tenosynovitis/effusion; nerve conduction studies for suspected entrapment neuropathy; MRI for occult fractures or soft-tissue pathology not resolved by initial imaging.
💡
Clinical pearl: Most arm and hand conditions can be diagnosed clinically without imaging. Reserve imaging for cases where fracture is suspected, diagnosis is unclear after 4–6 weeks of conservative management, or red flags are present. Plain X-rays are the first-line investigation for suspected bony injury; ultrasound is increasingly available in Australian general practice and is excellent for soft-tissue pathology.

Tennis Elbow (Lateral) & Medial Epicondylar Tendinopathy

Lateral Epicondylar Tendinopathy (Tennis Elbow)

Lateral epicondylar tendinopathy is a degenerative tendinopathy of the common extensor tendon origin, predominantly involving the extensor carpi radialis brevis (ECRB). Despite its colloquial name, it is more commonly associated with occupational activities (repetitive wrist extension, gripping, tool use) than sporting activity. Peak incidence is between 35 and 54 years, with equal sex distribution.

💡
Pathology note: Histologically, lateral epicondylar tendinopathy demonstrates angiofibroblastic hyperplasia rather than inflammatory cell infiltration, supporting the modern classification as a tendinopathy (degenerative) rather than tendinitis (inflammatory). This has implications for treatment — anti-inflammatory agents provide symptomatic relief but do not address the underlying degenerative process.

Clinical Features

  • Insidious onset of pain over the lateral epicondyle, radiating into the proximal forearm extensor mass.
  • Aggravated by gripping (shaking hands, turning door handles, lifting a cup) and resisted wrist extension.
  • Point tenderness directly over or just distal to the lateral epicondyle.
  • Cozen's test (resisted wrist extension with elbow extended) and Mills' test (passive wrist flexion with elbow extended) are provocative.
  • Grip strength is often reduced compared with the unaffected side.

Medial Epicondylar Tendinopathy (Golfer's Elbow)

Medial epicondylar tendinopathy involves the common flexor–pronator tendon origin, predominantly the flexor carpi radialis and pronator teres. It is less common than lateral epicondylitis (5–10:1 ratio) and is associated with repetitive wrist flexion and forearm pronation (golf, throwing sports, racquet sports, manual labour).

  • Pain over the medial epicondyle, worsened by resisted wrist flexion and pronation.
  • Point tenderness over the medial epicondyle; may be associated with ulnar nerve irritation (check for Tinel's sign at the cubital tunnel and paraesthesia in the ulnar nerve distribution).
  • Differential diagnosis: Cubital tunnel syndrome, UCL injury (especially in throwing athletes), cervical radiculopathy (C7–C8).

Investigations

Essential Clinical diagnosis No imaging required in typical presentations. Diagnosis rests on history and provocative testing.
Available Plain X-ray elbow (AP and lateral) Consider if fracture, loose body, or osteoarthritis is suspected. MBS item 57300. May show calcification at tendon origin in chronic cases.
Available Musculoskeletal ultrasound Excellent for visualising tendon thickening, partial tears, and neovascularity. Increasingly available in Australian general practice and sports medicine clinics.
Referral MRI elbow Reserved for refractory cases, suspected UCL injury, or when surgical planning is being considered. MBS item 63341.
Specialist Nerve conduction studies Consider if cubital tunnel syndrome or other entrapment neuropathy is suspected alongside epicondylar tendinopathy. MBS item 11014.

Management

Conservative (First-line — 80–90% resolve within 12 months)

💊
Paracetamol
Panadol® · Generic · Simple analgesic
Adult dose 500–1000 mg PO up to QID (max 4 g/day)
Paediatric dose 15 mg/kg PO QDS PRN (max 60 mg/kg/day)
Duration As needed, PRN
Renal adjustment eGFR <10 mL/min: reduce dose and frequency; consult pharmacy
Hepatic adjustment Contraindicated in severe hepatic impairment; max 2 g/day in significant liver disease
PBS status ✔ PBS General Benefit
💊
Ibuprofen
Nurofen® · Generic · NSAID
Adult dose 200–400 mg PO TDS-QDS with food (max 1200 mg/day OTC; 2400 mg/day Rx)
Paediatric dose 5–10 mg/kg PO TDS (max 30 mg/kg/day)
Duration Short course (1–2 weeks) for acute flares
Renal adjustment Avoid if eGFR <30 mL/min; use with caution if eGFR 30–60
Hepatic adjustment Avoid in severe hepatic impairment
PBS status ✔ PBS General Benefit
💊
Celecoxib
Celebrex® · Selective COX-2 inhibitor
Adult dose 200 mg PO daily, or 100 mg BD; max 400 mg/day
Duration 2–4 weeks for acute exacerbations; review at 2 weeks
Renal adjustment Avoid if eGFR <30 mL/min
Hepatic adjustment Contraindicated in severe hepatic impairment (Child–Pugh C)
PBS status ▲ PBS Authority Required
Key management principle: Progressive eccentric and isometric loading exercises of the wrist extensors (lateral epicondylitis) or flexors (medial epicondylitis) are the cornerstone of rehabilitation. Refer to a physiotherapist experienced in tendinopathy management. A structured exercise programme over 8–12 weeks yields the best long-term outcomes.

Corticosteroid Injection

Corticosteroid injection (e.g., triamcinolone acetonide 20 mg or methylprednisolone acetate 20–40 mg with 1–2 mL 1% lignocaine) may provide short-term pain relief (4–8 weeks) but is associated with higher recurrence rates and worse long-term outcomes compared with physiotherapy alone at 12 months (Coombes et al., 2013). Consider injection only when:

  • Symptoms are severe and impacting work/function despite 4–6 weeks of conservative management.
  • Patient has declined or cannot access physiotherapy.
  • Maximum of two injections per episode, separated by at least 6 weeks.

Referral & Surgical Options

Refer to an orthopaedic surgeon or sports medicine physician if symptoms persist beyond 6–12 months despite optimal conservative management. Surgical options include open or arthroscopic extensor tendon release (lateral epicondylar debridement) or ECRB release. Success rates for surgery range from 70–90% but recovery takes 3–6 months.

⚠️
Do not inject if there is: Overlying infection, suspected fracture, systemic sepsis, or local skin conditions. Avoid repeated injections (more than 3 per year at the same site) due to risk of tendon rupture and cartilage damage.

Carpal Tunnel Syndrome

Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy, caused by compression of the median nerve at the wrist within the carpal tunnel. It has a prevalence of 3–6% in the Australian adult population, with a peak incidence in women aged 45–64 years. Risk factors include female sex, obesity, pregnancy, diabetes mellitus, hypothyroidism, rheumatoid arthritis, repetitive wrist flexion activities, and genetic predisposition.

Pathophysiology

The carpal tunnel is a rigid fibro-osseous space bounded by the carpal bones dorsally and the transverse carpal ligament (flexor retinaculum) volarly. The median nerve and nine flexor tendons traverse this space. Any condition that increases the contents (e.g., tenosynovitis, oedema, space-occupying lesions) or decreases the volume (e.g., wrist fractures with displacement, osteophytes) will elevate pressure and compress the median nerve. Chronic compression leads to demyelination and, if prolonged, axonal degeneration.

Clinical Features

  • Symptoms: Nocturnal paraesthesia and numbness in the median nerve distribution (thumb, index, middle, and radial half of ring finger). Patients often describe waking with a "dead hand" and shaking it to relieve symptoms (flick sign).
  • Aggravating factors: Prolonged wrist flexion (driving, holding a phone, reading), repetitive gripping.
  • Advanced features: Thenar muscle wasting (abductor pollicis brevis), weakness of thumb opposition, loss of two-point discrimination.
  • Provocation tests: Phalen's test (wrist flexion for 60 seconds reproduces symptoms), Tinel's test (percussion over the carpal tunnel), carpal compression test (direct pressure over the carpal tunnel for 30 seconds).

Severity Grading

Mild
Intermittent Symptoms
Intermittent paraesthesia, mainly nocturnal. No motor deficit. No thenar wasting. NCS: prolonged sensory latency only.
Setting: GP management — conservative
Moderate
Persistent Symptoms
Persistent paraesthesia/numbness, may have mild thenar weakness but no visible wasting. Symptoms affect daily activities. NCS: prolonged sensory and motor latencies.
Setting: GP with consideration for injection; specialist referral if no response
Severe
Motor Deficit / Thenar Atrophy
Visible thenar wasting, weakness of thumb abduction and opposition, constant numbness. NCS: absent sensory potentials and reduced CMAP amplitude. Irreversible nerve damage may occur.
Setting: Urgent specialist referral — surgery indicated

Investigations

Essential Clinical diagnosis Typical presentation with positive provocative tests is diagnostic in most cases. The CTS-6 clinical prediction rule can assist when diagnosis is uncertain.
Available Nerve conduction studies (NCS) / Electromyography (EMG) Gold standard to confirm diagnosis and grade severity. Recommended before surgical referral or when atypical features are present. MBS item 11014 (upper limb). Available in most major Australian centres and many regional areas.
Available Blood tests TFTs (hypothyroidism), HbA1c (diabetes), ESR/CRP (inflammatory conditions) — identify and treat underlying causes in bilateral or atypical presentations.
Referral Ultrasound wrist Can demonstrate median nerve enlargement (cross-sectional area >10 mm² at the carpal tunnel inlet) and tenosynovitis. Increasingly used as an adjunct to NCS.
Referral MRI wrist Reserved for suspected space-occupying lesions, ganglia, or when NCS/ultrasound is inconclusive. MBS item 63341.

Management

Conservative (First-line for mild to moderate CTS)

🔧
Wrist Splint (Neutral Position)
Cock-up wrist splint · Various brands
Indication Mild to moderate CTS; first-line treatment
Use Wear at night (minimum) and during aggravating daytime activities. Neutral wrist position (0° extension).
Duration Minimum 6–12 weeks; continue if beneficial
Evidence RCT evidence supports nocturnal splinting for symptom relief in mild CTS (Page et al., Cochrane 2012)
PBS status ✔ Available OTC; some private health funds cover custom splints
💊
Methylprednisolone acetate (local injection)
Depo-Medrol® · Corticosteroid
Adult dose 40 mg (1 mL) injected into the carpal tunnel using a 25G needle, with 1 mL 1% lignocaine
Technique Palmar approach: inject at the proximal wrist crease, ulnar to palmaris longus tendon, directed distally at 30–45°. Avoid intraneural injection.
Duration of effect Symptom relief for 1–3 months; effect may wane over time
Maximum Up to 2 injections, separated by ≥ 3 months. If symptoms recur, refer for surgical opinion.
PBS status ✔ PBS General Benefit (when administered by a medical practitioner)

Surgical Management

Carpal tunnel release (open or endoscopic) is indicated for:

  • Severe CTS with thenar atrophy or significant motor deficit.
  • Moderate CTS that has failed 12 weeks of conservative management.
  • Patient preference when the diagnosis is confirmed by NCS.

Surgery involves division of the transverse carpal ligament (flexor retinaculum) to decompress the median nerve. Success rates are 85–95%. Endoscopic release may offer faster functional recovery. Complications (uncommon) include pillar pain, incomplete release, nerve injury, and complex regional pain syndrome.

⚠️
Pregnancy-related CTS: Up to 50% of pregnant women experience CTS symptoms, typically in the third trimester. Conservative management (splints, activity modification) is first-line; most cases resolve postpartum. Avoid corticosteroid injection during pregnancy unless symptoms are severe and refractory. If surgery is required, it is safest in the second trimester or postpartum.

Pulled Elbow in Children

Pulled elbow (radial head subluxation, "nursemaid's elbow") is the most common upper limb injury in children under 5 years of age. It typically occurs in children aged 1–4 years and is caused by sudden longitudinal traction on the extended arm — for example, when a child is lifted or swung by the hand or wrist, or when a child suddenly jerks away while being held by the hand.

Pathophysiology

In young children, the radial head is smaller in diameter than the radial neck, and the annular ligament is relatively lax. Sudden traction on the forearm with the arm extended and the forearm pronated allows the annular ligament to slip over the radial head and become trapped in the radiohumeral joint. As the child grows (typically by age 5), the radial head enlarges and the annular ligament strengthens, making subluxation increasingly unlikely.

Clinical Features

  • History: Sudden pull on the arm; the child immediately cries and refuses to use the affected arm.
  • Examination: The arm is held in slight flexion and pronation at the side. The child resists all attempts at supination and elbow extension. There is no swelling, deformity, or localised tenderness.
  • Key point: If there is swelling, ecchymosis, deformity, or point tenderness, suspect a fracture (particularly supracondylar or distal radius fracture) rather than pulled elbow.
🚨
Red flag — Non-accidental injury (NAI): In any young child presenting with arm pain or injury, consider the possibility of non-accidental injury. Red flags for NAI include: inconsistent history, delay in presentation, injuries at different stages of healing, other unexplained injuries, and the child being in the care of a non-family member. Report suspected child abuse to your state/territory child protection authority or contact the relevant child protection helpline. In New South Wales: 132 111. In Victoria: 1300 360 391.

Investigations

Essential Clinical diagnosis Classic history and examination findings are sufficient. No imaging is required for typical presentations.
Available Plain X-ray elbow (AP and lateral) Indicated if: history is atypical, there is swelling/deformity/tenderness, the child is older than 5 years, or the mechanism suggests higher-energy trauma. MBS item 57300. X-rays are typically normal in pulled elbow.

Reduction Techniques

Pulled elbow can be reduced in the clinic, emergency department, or urgent care setting without sedation or imaging. Two techniques have comparable success rates (80–95% on first attempt):

Technique 1: Supination–Flexion

Stabilise the elbow with one hand. With the other hand, firmly supinate the forearm while applying gentle pressure over the radial head, then flex the elbow fully. A palpable or audible "click" is often felt.

Technique 2: Hyperpronation

Stabilise the elbow with one hand. With the other hand, firmly pronate the forearm (forced pronation) while applying gentle pressure over the radial head. This technique may have a slightly higher first-attempt success rate (range 90–97%).

💡
Post-reduction assessment: After successful reduction, the child should begin using the arm within 10–15 minutes. Offer an appealing toy or object to encourage reaching. If the child does not use the arm after 20–30 minutes, consider repeat reduction attempt (second technique) or X-ray to exclude fracture. Immobilisation is not required after successful reduction.

Parent Education

  • Explain the mechanism and reassure that this is a common, benign injury.
  • Advise against lifting or swinging children by the hands or wrists.
  • Recurrence occurs in approximately 20–40% of cases; advise parents to seek early reduction if it recurs.
  • If recurrent episodes occur, consider orthopaedic or paediatric referral for assessment and potential casting to allow ligamentous tightening (rarely required).
⚠️
When NOT to attempt reduction: Do not attempt reduction if there is swelling, deformity, ecchymosis, or point tenderness — these suggest fracture, not pulled elbow. Obtain X-rays and manage accordingly. Also avoid repeated forceful attempts; after two unsuccessful attempts, obtain imaging and refer to the emergency department.

Special Populations

🤰 Pregnancy
Carpal tunnel syndrome is common in pregnancy (up to 50%) due to fluid retention and hormonal changes affecting connective tissue. Most cases resolve postpartum.
Management: Nocturnal wrist splints, ergonomic modification, gentle exercises. Avoid corticosteroid injection unless symptoms are severe and functionally disabling.
Analgesia: Paracetamol is preferred. Avoid NSAIDs, especially in the third trimester (risk of premature closure of the ductus arteriosus and oligohydramnios).
If CTS is bilateral and severe, screen for gestational diabetes and pre-eclampsia.
👶 Paediatrics
Pulled elbow is the most common upper limb injury in children under 5. Reduced by supination–flexion or hyperpronation technique; no imaging required for classic presentation.
Supracondylar fracture must be excluded in any child with elbow pain, swelling, and inability to extend the elbow after a fall. Always check neurovascular status (anterior interosseous nerve, brachial artery).
Non-accidental injury: Consider and document in all paediatric presentations. Document the history given, examination findings, and any concerns.
Analgesia: Paracetamol (15 mg/kg) and ibuprofen (5–10 mg/kg) for pain. Weight-based dosing is essential.
Elbow ossification centres appear in a predictable order (CRITOL: Capitulum 1yr, Radial head 3yr, Internal [medial] epicondyle 5yr, Trochlea 7yr, Olecranon 9yr, Lateral epicondyle 11yr). Disruption of this pattern on X-ray may indicate fracture.
👴 Elderly
Falls are the most common mechanism of arm injury in the elderly. Colles' fracture (distal radius), scaphoid fracture, and humeral fractures are frequent.
Osteoarthritis of the first carpometacarpal joint (base of thumb) is common and presents with pain on gripping and pinching. Management includes splints, topical NSAIDs, and hand therapy.
Consider osteoporosis assessment (FRAX score, DEXA) in any older adult presenting with a low-energy fracture of the arm or wrist.
NSAIDs: Use with caution due to increased risk of GI bleeding, renal impairment, and cardiovascular events. Prefer short courses, topical formulations, or paracetamol ± low-dose opioids.
Check renal function (eGFR) before prescribing NSAIDs in patients over 65 years.
🫘 Renal Impairment
NSAIDs: Avoid if eGFR <30 mL/min; use with caution and reduced duration if eGFR 30–60 mL/min. Monitor renal function and potassium.
Dialysis-related CTS: CTS is significantly more common in patients on long-term haemodialysis (amyloid deposition). Refer to nephrology and hand surgery for assessment.
Paracetamol: Safe at standard doses (max 2 g/day in severe CKD/eGFR <10 mL/min is a conservative approach, though many guidelines still permit up to 4 g/day).
Gabapentin (for neuropathic pain) requires dose reduction in CKD: 200–300 mg once daily if eGFR <15 mL/min.
🛡️ Immunocompromised
Corticosteroid injections: Use with caution in immunocompromised patients (transplant recipients, patients on biologics, uncontrolled diabetes) due to increased infection risk. Consider ultrasound guidance and strict aseptic technique.
Septic arthritis/osteomyelitis: Have a lower threshold for investigation if elbow or wrist pain is accompanied by erythema, warmth, or systemic features. Blood cultures and joint aspiration are essential.
Diabetic neuropathy: May mimic or co-exist with CTS. Nerve conduction studies are particularly helpful to differentiate and quantify.
Steroid injections may transiently raise blood glucose in diabetic patients; advise monitoring for 48–72 hours post-injection.

Aboriginal and Torres Strait Islander Health

Aboriginal and Torres Strait Islander Health Considerations
Prevalence & Burden
Musculoskeletal conditions are among the most common health complaints in Aboriginal and Torres Strait Islander peoples, with rates 1.4 times higher than in the non-Indigenous population (AIHW, 2024). Arm and hand pain, including work-related upper limb disorders, is prevalent in communities with high rates of manual labour and outdoor work.
Access to Specialist Care
Many Aboriginal and Torres Strait Islander Australians live in rural and remote areas with limited access to orthopaedic surgeons, hand therapists, and nerve conduction study facilities. The Royal Flying Doctor Service (RFDS) and specialist outreach programmes (e.g., through Aboriginal Community Controlled Health Organisations — ACCHOs) are essential for managing conditions requiring specialist input.
Cultural Safety
Healthcare should be delivered in a culturally safe environment. Acknowledge the patient's connection to Country and family. Use Aboriginal Health Workers (AHWs) and Aboriginal Health Practitioners (AHPs) as key intermediaries in assessment, education, and follow-up. Ensure gender-sensitive care where relevant (e.g., male patients may prefer a male clinician for certain examinations).
Child Health & Non-Accidental Injury
Pulled elbow and paediatric arm fractures require sensitive assessment. Be aware of the historical over-representation of Aboriginal and Torres Strait Islander families in the child protection system. Apply the same clinical thresholds for NAI concern as for all children, but ensure culturally appropriate, trauma-informed communication and involve family and community supports.
Work-Related Injury
Aboriginal and Torres Strait Islander workers may have higher rates of manual labour in industries such as mining, agriculture, construction, and community services. Workplace health and safety (WHS) modifications, early reporting, and access to workers' compensation are critical. Ensure patients are aware of their entitlements under state/territory WHS legislation.
Diabetes & Comorbidity
Aboriginal and Torres Strait Islander Australians have a diabetes prevalence approximately 3.5 times higher than the non-Indigenous population. Diabetic neuropathy may co-exist with or mimic CTS, and diabetes increases the risk of adverse outcomes from corticosteroid injections (infection, poor wound healing, glycaemic disturbance). Screen HbA1c before considering injection.
Telehealth & Digital Health
Telehealth (MBS items 91800–91801 and related items) can facilitate specialist review for arm and hand conditions in remote areas. Photo-based triage, video consultations, and store-and-forward imaging can reduce the need for patient travel. Ensure digital literacy and connectivity challenges are considered and supported.

📚 References

  1. 1. Australian Institute of Health and Welfare (AIHW). Musculoskeletal conditions in Australia. AIHW; 2024. Available from: https://www.aihw.gov.au
  2. 2. Britt H, Miller GC, Bayram C, et al. A decade of Australian general practice activity 2013–14 to 2022–23. Sydney: Sydney University Press; 2023. General Practice Series No. 42.
  3. 3. Coombes BK, Bisset L, Brooks P, Khan A, Vicenzino B. Effect of corticosteroid injection, physiotherapy, or both on clinical outcomes in patients with unilateral lateral epicondylalgia: a randomized controlled trial. JAMA. 2013;309(5):461–469.
  4. 4. Bisset L, Beller E, Jull G, Brooks P, Darnell R, Vicenzino B. Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. BMJ. 2006;333(7575):939.
  5. 5. Page MJ, O'Connor D, Pitt V, Massy-Westropp N. Exercise and mobilisation interventions for carpal tunnel syndrome. Cochrane Database Syst Rev. 2012;(6):CD009899.
  6. 6. Bland JD. Carpal tunnel syndrome. BMJ. 2007;335(7615):343–346.
  7. 7. Bektaş H, Baysal Ö, Sarı E, Özdemi̇r T, Aysal F. The efficacy of hyperpronation versus supination-flexion technique in the reduction of radial head subluxation. Pediatr Emerg Care. 2019;35(6):410–413.
  8. 8. Schutzman SA, Teach S. Radial head subluxation (nursemaid's elbow). UpToDate. Wolters Kluwer; 2024.
  9. 9. Royal Australian College of General Practitioners (RACGP). Guidelines for preventive activities in general practice (Red Book). 9th ed. Melbourne: RACGP; 2018.
  10. 10. Australian Commission on Safety and Quality in Health Care (ACSQHC). National Safety and Quality Health Service Standards. 2nd ed. Sydney: ACSQHC; 2021.
  11. 11. Nirschl RP. The surgical treatment of lateral epicondylitis. J Bone Joint Surg Am. 1979;61(6):832–839.
  12. 12. National Health and Medical Research Council (NHMRC). National Statement on Ethical Conduct in Human Research. Canberra: NHMRC; 2023 (updated).
  13. 13. de Krom MC, Kester AD, Knipschild PG, Spaans F. Risk factors for carpal tunnel syndrome. Am J Epidemiol. 1990;132(6):1102–1110.
  14. 14. Australian Government Department of Health and Aged Care. Medicare Benefits Schedule (MBS) Online. Canberra: Commonwealth of Australia; 2024. Available from: http://www.mbsonline.gov.au
for PBS scripts. Utilise ACCHS pharmacies and Remote Area Aboriginal Health Worker programs for medication supply in remote areas. Avoid initiating benzodiazepines; support holistic pain management including community-based exercise programs.
Preventive health
Promote bone health: encourage vitamin D supplementation (1000 IU daily in deficient individuals), smoking cessation support, reduction of alcohol intake, and weight-bearing exercise. MBS Item 715 health checks provide a structured opportunity to assess bone health, screen for osteoporosis risk factors, and discuss musculoskeletal health in a culturally safe context.

Quick Reference: Differential Diagnosis at a Glance

Costovertebral dysfunction
Paracetamol ± NSAID; manual therapy
2–6 weeks
Provocable on palpation; no red flags
Thoracic compression fracture
Paracetamol; ± calcitonin; DXA + osteoporosis Rx
6–12 weeks healing
Elderly; osteoporosis; acute onset
ACS (posterior MI)
Aspirin 300 mg, GTN, heparin; urgent PCI
Time-critical
ECG, troponin; CV risk factors
Aortic dissection
IV labetalol; urgent CT aortogram; surgery (Type A)
Time-critical
Tearing pain; BP differential >20 mmHg
Vertebral osteomyelitis
IV antibiotics (vancomycin + ceftriaxone initially); ID consult
6 weeks IV antibiotics
Fever, elevated CRP, IV drug use
Biliary colic / cholecystitis
Paracetamol ± morphine; lap cholecystectomy
Surgical within 72 h (cholecystitis)
RUQ/infrascapular; post-prandial; RUQ US

📚 References

  1. 1. Briggs AM, Smith AJ, Straker LM, Bragge P. Thoracic spine pain in the general population: prevalence, incidence and associated factors in children, adolescents and adults. A systematic review. BMC Musculoskelet Disord. 2009;10:77.
  2. 2. National Health and Medical Research Council (NHMRC). Evidence-based management of acute musculoskeletal pain. Canberra: NHMRC; 2003 (updated 2020).
  3. 3. Australian Institute of Health and Welfare (AIHW). Aboriginal and Torres Strait Islander Health Performance Framework: Summary report 2023. Canberra: AIHW; 2023.
  4. 4. Deyo RA, Rainville J, Kent DL. What can the history and physical examination tell us about low back pain? JAMA. 1992;268(6):760–765.
  5. 5. Stochkendahl MJ, Kjaer P, Hartvigsen J, et al. National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy. Europ Spine J. 2018;27(1):60–75.
  6. 6. Erwin WM, Jackson PC, Homonko DA. Innervation of the human costovertebral joint: implications for clinical back pain syndromes. J Manipulative Physiol Ther. 2000;23(6):395–403.
  7. 7. Royal Australian College of General Practitioners (RACGP). Guidelines for preventive activities in general practice. 9th edn. Melbourne: RACGP; 2018 (updated 2023).
  8. 8. Hirsch JA, Singh V, Falco FJE, et al. Thoracic facet joint interventions. Pain Physician. 2016;19(4):E581–E593.
  9. 9. Erwin WM, Jackson PC. The costovertebral joint: anatomy, biomechanics, and clinical significance in thoracic back pain syndromes. J Can Chiropr Assoc. 2003;47(2):112–120.
  10. 10. Strayer RJ, Gunnerson JM, Brown LH, et al. Aortic dissection: clinical features, diagnosis, and management. Aust Crit Care. 2019;32(2):144–153.
  11. 11. Ombregt L. A system of orthopaedic medicine. 3rd edn. Edinburgh: Churchill Livingstone Elsevier; 2013. Chapter 18: Thoracic spine.
  12. 12. Lin CC, Chen KH, Li DM, et al. Characteristics and outcomes of patients presenting with thoracic back pain to the emergency department. Emerg Med Australas. 2020;32(5):805–811.
for PBS-listed medicines at participating pharmacies.
Cultural safety
Engagement with Aboriginal Community Controlled Health Organisations (ACCHOs) is essential. Cultural safety training for non-Indigenous clinicians, use of Aboriginal Health Workers and Liaison Officers, and incorporation of traditional healing practices alongside Western medicine improve treatment adherence and outcomes. Avoidance of eye contact, respect for gender-sensitive examination practices, and understanding of sorry business protocols are critical elements of culturally safe care.
Medication adherence
Complex DMARD regimens with frequent monitoring requirements present adherence challenges. Long-acting depot injections (e.g., methotrexate SC) may improve adherence compared to oral regimens. Community pharmacy partnerships through the Indigenous Pharmacy Programmes improve medication management.
Specific conditions
Rheumatic heart disease (RHD) requires secondary prophylaxis with benzathine penicillin G (BPG) 1.2 MU IM every 3–4 weeks for a minimum of 10 years or until age 21 (whichever is longer). RHD registers (e.g., NT RHD Register) facilitate recall and follow-up. The Australian RHD Endgame Strategy targets elimination by 2031.
Referral pathways
Referral through ACCHOs and Aboriginal Hospital Liaison Officers (AHLOs) improves engagement. The Specialist Outreach Assistance Programme provides funded specialist visits to remote communities. NT, WA, and QLD have specific rheumatology outreach programmes targeting Indigenous communities.

📚 References

  1. 1. Australian Institute of Health and Welfare (AIHW). Autoimmune disease in Australia. Cat. no. PHE 312. Canberra: AIHW; 2023.
  2. 2. Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2021;73(7):924–939.
  3. 3. Fanouriakis A, Kostopoulou M, Alber K, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–745.
  4. 4. Chung SA, Langford CA, Maz M, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res. 2021;73(11):1583–1599.
  5. 5. Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3–18.
  6. 6. Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. Australian Government Department of Health; 2024. Available from: immunisationhandbook.health.gov.au.
  7. 7. Rheumatic Heart Disease Australia (RHDAustralia). The 2020 Australian guideline for prevention, diagnosis, and management of acute rheumatic fever and rheumatic heart disease. 3rd ed. Darwin: Menzies School of Health Research; 2020.
  8. 8. Pharmaceutical Benefits Scheme (PBS). PBS Schedule. Australian Government Department of Health. Available from: pbs.gov.au. Accessed 2024.
  9. 9. Agarwal S, Cunnington J, Nossent J. Autoimmune disease in Indigenous Australians: a systematic review. Int J Rheum Dis. 2021;24(12):1487–1498.
  10. 10. Pisetsky DS. Antinuclear antibody testing — misunderstood or misused? Clin Immunol. 2023;255:109717.
  11. 11. Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012;71(11):1771–1782.
  12. 12. Ledingham J, Deighton C; British Society for Rheumatology Standards, Audit and Guidelines Working Group. Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis. Rheumatology. 2005;44(2):155–158.
  13. 13. National Health and Medical Research Council (NHMRC). National statement on ethical conduct in human research. Canberra: NHMRC; 2023 (updated).
for PBS-listed medicines at participating pharmacies.
Cultural safety
Engagement with Aboriginal Community Controlled Health Organisations (ACCHOs) is essential. Cultural safety training for non-Indigenous clinicians, use of Aboriginal Health Workers and Liaison Officers, and incorporation of traditional healing practices alongside Western medicine improve treatment adherence and outcomes. Avoidance of eye contact, respect for gender-sensitive examination practices, and understanding of sorry business protocols are critical elements of culturally safe care.
Medication adherence
Complex DMARD regimens with frequent monitoring requirements present adherence challenges. Long-acting depot injections (e.g., methotrexate SC) may improve adherence compared to oral regimens. Community pharmacy partnerships through the Indigenous Pharmacy Programmes improve medication management.
Specific conditions
Rheumatic heart disease (RHD) requires secondary prophylaxis with benzathine penicillin G (BPG) 1.2 MU IM every 3–4 weeks for a minimum of 10 years or until age 21 (whichever is longer). RHD registers (e.g., NT RHD Register) facilitate recall and follow-up. The Australian RHD Endgame Strategy targets elimination by 2031.
Referral pathways
Referral through ACCHOs and Aboriginal Hospital Liaison Officers (AHLOs) improves engagement. The Specialist Outreach Assistance Programme provides funded specialist visits to remote communities. NT, WA, and QLD have specific rheumatology outreach programmes targeting Indigenous communities.

📚 References

  1. 1. Australian Institute of Health and Welfare (AIHW). Autoimmune disease in Australia. Cat. no. PHE 312. Canberra: AIHW; 2023.
  2. 2. Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2021;73(7):924–939.
  3. 3. Fanouriakis A, Kostopoulou M, Alber K, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–745.
  4. 4. Chung SA, Langford CA, Maz M, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res. 2021;73(11):1583–1599.
  5. 5. Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3–18.
  6. 6. Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. Australian Government Department of Health; 2024. Available from: immunisationhandbook.health.gov.au.
  7. 7. Rheumatic Heart Disease Australia (RHDAustralia). The 2020 Australian guideline for prevention, diagnosis, and management of acute rheumatic fever and rheumatic heart disease. 3rd ed. Darwin: Menzies School of Health Research; 2020.
  8. 8. Pharmaceutical Benefits Scheme (PBS). PBS Schedule. Australian Government Department of Health. Available from: pbs.gov.au. Accessed 2024.
  9. 9. Agarwal S, Cunnington J, Nossent J. Autoimmune disease in Indigenous Australians: a systematic review. Int J Rheum Dis. 2021;24(12):1487–1498.
  10. 10. Pisetsky DS. Antinuclear antibody testing — misunderstood or misused? Clin Immunol. 2023;255:109717.
  11. 11. Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012;71(11):1771–1782.
  12. 12. Ledingham J, Deighton C; British Society for Rheumatology Standards, Audit and Guidelines Working Group. Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis. Rheumatology. 2005;44(2):155–158.
  13. 13. National Health and Medical Research Council (NHMRC). National statement on ethical conduct in human research. Canberra: NHMRC; 2023 (updated).